ArticleRetrovirology2015

Long lasting control of viral rebound with a new drug ABX464 targeting Rev - mediated viral RNA biogenesis.

Noëlie Campos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.